Flow Traders U.S.’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $931K | Buy |
+45,404
| New | +$931K | 0.03% | 434 |
|
|
2025
Q1 | – | Sell |
-94,333
| Closed | -$2.14M | – | 1108 |
|
|
2024
Q4 | $2.14M | Buy |
+94,333
| New | +$2.14M | 0.09% | 200 |
|
|
2022
Q4 | – | Sell |
-11,470
| Closed | -$303K | – | 989 |
|
|
2022
Q3 | $303K | Buy |
+11,470
| New | +$303K | 0.02% | 627 |
|
|
2022
Q2 | – | Sell |
-43,315
| Closed | -$1.49M | – | 911 |
|
|
2022
Q1 | $1.49M | Buy |
+43,315
| New | +$1.49M | 0.05% | 297 |
|
|
2021
Q4 | – | Sell |
-19,542
| Closed | -$991K | – | 912 |
|
|
2021
Q3 | $991K | Buy |
19,542
+14,068
| +257% | +$713K | 0.04% | 491 |
|
|
2021
Q2 | $285K | Sell |
5,474
-7,152
| -57% | -$372K | 0.01% | 753 |
|
|
2021
Q1 | $577K | Buy |
12,626
+6,270
| +99% | +$287K | 0.03% | 465 |
|
|
2020
Q4 | $292K | Buy |
+6,356
| New | +$292K | 0.02% | 497 |
|